Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung cancer.

Irfan Maghfoor1, Michael C Perry

  • 1Department of Oncology, King Faisal Specialist Hospital & Research Centre, PO. Box 3354 (MBC 64) Riyadh 11211, Saudi Arabia.

Annals of Saudi Medicine
|April 13, 2005
PubMed
Summary
This summary is machine-generated.

Lung cancer remains a leading cause of cancer death, with smoking driving incidence. While early-stage non-small cell lung cancer offers curative potential, advanced stages and widespread small cell lung cancer are largely incurable.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Blood advances·2026
Same author

Pregnancy after hematopoietic stem cell transplant: an international multicenter study.

Blood advances·2026
Same author

Treatment Outcome and Chemoresistance-Related Factors of Low-Risk Gestational Trophoblastic Neoplasia: Results From a Tertiary Care Center in Saudi Arabia.

JCO global oncology·2025
Same author

Risk of hematological malignancies and anticipation in the families of patients with non-Hodgkin and Hodgkin lymphoma.

Frontiers in oncology·2025
Same author

Impact of Risk Factors on Long-Term Survival and Post-Transplant Failure Management in 200 Aggressive Non-Hodgkin Lymphoma Patients Who Underwent High-Dose Chemotherapy and Autologous Stem Cell Transplantation.

Transplantation and cellular therapy·2025
Same author

Outcomes of Adolescent LBCL Patients Treated With Adult Type Chemotherapy: A Single Center Experience.

Clinical lymphoma, myeloma & leukemia·2025
Same journal

Epidemiology and risk factors of colorectal polyp detection: a regional, single-center retrospective study.

Annals of Saudi medicine·2026
Same journal

Acute exacerbation of chronic rhinosinusitis: clinical and microbiological perspectives from a Saudi tertiary care center.

Annals of Saudi medicine·2026
Same journal

Age-related patterns in hysterectomy: indications and surgical route selection in a three-year tertiary-center cohort.

Annals of Saudi medicine·2026
Same journal

Diagnostic utility and limitations of CT-guided transthoracic fine-needle aspiration biopsy in Lung-RADS 4 pulmonary nodules ≤2 cm.

Annals of Saudi medicine·2026
Same journal

Association between proton pump inhibitor use and vitamin B12 deficiency: a retrospective cohort study in primary care centers in Riyadh, Saudi Arabia.

Annals of Saudi medicine·2026
Same journal

Comparative overall survival in T4N0 and T2-3N1 non-metastatic colon cancer: a retrospective cohort study.

Annals of Saudi medicine·2026
See all related articles

Area of Science:

  • Oncology
  • Pulmonology
  • Cancer Research

Background:

  • Lung cancer is the primary cause of cancer mortality globally.
  • Tobacco smoking is the predominant risk factor, predicting rising incidence in high-smoking regions.
  • Despite identifiable at-risk populations, evidence does not support mass lung cancer screening.

Purpose of the Study:

  • To review the current therapeutic strategies and prognoses for different types and stages of lung cancer.
  • To highlight the potential for curative treatment in early-stage disease and the challenges in advanced stages.
  • To acknowledge the ongoing development of molecular targeted therapies for lung cancer.

Main Methods:

  • Review of existing literature on lung cancer epidemiology, diagnosis, and treatment.

Related Experiment Videos

  • Analysis of treatment outcomes for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
  • Discussion of current therapeutic modalities including surgery, chemotherapy, radiation, and emerging targeted therapies.

    • Main Results:

    • Early-stage NSCLC may be curable with surgery and adjuvant chemotherapy.
    • Locally advanced NSCLC might benefit from neoadjuvant therapy to facilitate surgical resection.
    • Advanced NSCLC and SCLC with distant metastasis are generally considered incurable with current strategies.

    Conclusions:

    • Curative treatment for lung cancer is feasible only in specific early-stage presentations.
    • Significant advancements in molecular targeted therapies are underway to address the molecular pathways in lung cancer.
    • Improved therapeutic strategies are needed for advanced lung cancer to improve patient outcomes.